All News

AstraZeneca’s Niko Andre discusses the power of patient partnership in driving medical progress.

Analytic work will drive regulatory grade RWD studies and therapeutic evidence to improve patient outcomes.

Novo Nordisk announces plans to invest more than 17bn Danish kroner constructing three new manufacturing facilities in Kalundborg, Denmark.​

Pharma executives cite supply chain visibility as critical solution to alleviating product loss and security concerns, while one-third are dissatisfied with current solutions.

Workplace equality accelerating for healthcare industry’s Gender Parity Collaborative.

The White House nominates Robert Califf to once again take the reins of FDA, but acting commissioner Janet Woodcock will remain in place during the Senate confirmation process.

Merck and Ridgeback Biotherapeutics’ anti-viral pill is reported to halve the risk of hospitalization or death.

Solution leverages AI and natural language processing to accelerate and improve the review of materials used to market pharmaceutical and medical device products.

Carlyle and co-investors including Amgen Ventures, Merck Global Health Innovation Fund, Pfizer Ventures, and Population Health Partners to acquire majority stake in Saama Technologies.

Rebrand launched to design, develop, and deliver specialist training, skills assessments and process consultancy to the healthcare and pharma industries.

PharmaLex has announced the launch of a new service line, Biopharma Excellence, and appointed a new Chief Medical Officer.

With the headlines focused on COVID-19, many may have forgotten about the escalating epidemic of substance use disorder. National Recovery Month is a time to bring this issue back to the top of the agenda, raise awareness, and drive action, writes Richard Pops, CEO of Alkermes.

At this point of the evolving RWD landscape, we thought it appropriate to begin to broadly assess the use of real world data.

OM Pharma, active in the prevention of recurrent respiratory and urinary tract infections, wins the 2021 Geneva Economy Award.

Coupled with broader migration trends happening in the US, new upstart locations become increasingly attractive for investors, developers, tenants, and landlords.

Merck and Otsuka recognized for driving greater equality for women in the workplace.

FDA is launching a program to test the safety and suitability of novel inactive ingredients for use in new drugs and biologics.

17 abstracts highlighting safety and efficacy to be shared at upcoming conference.

Medical Information (MI) Contact Center services now deploy AI-powered virtual agents alongside skilled human agents to triage and respond to inquiries.

Funding will be used to further develop CC Bio’s microbiome editing technologies, which harness potent enzymes derived from bacterial viruses to seek out and destroy harmful and disease-causing bacteria.

Partnership pairs Aktana’s Contextual Intelligence Engine with Real Chemistry’s data and creative campaign.

Laura Steele will lead Lilly’s commercial business operations in six countries, across the company’s current and emerging portfolio in Diabetes, Oncology, Immunology and Neuroscience.

What can both public and private sector stakeholders learn from current trends to accelerate innovation around the COVID-19 pandemic and other emerging global health threats, including antimicrobial resistance?

New findings detail how executives handle compliance challenges.

Will oversee global acceleration and scaling of ZS’ portfolio of life sciences and healthcare work.

Novartis and the Novartis US Foundation have launched a 10-year commitment to co-create programs “that address the root causes of systemic disparities in health outcomes and create greater diversity, equity and inclusion across the research and development ecosystem.”

ProductLife Group has announced its acquisition of Czech Republic-based global regulatory outsourcing company, ELC Group.